Physician profile
Tim Huston
NPI 1124091129
$408.73
in general payments reported to CMS, 2019-2025
12 companies · $91.50 in 2025
The $91.50 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25.00 · 2020: $48.46 · 2022: $23.68 · 2023: $81.38 · 2024: $139 · 2025: $91.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $312.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $311.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $66.85 | 2020-2024 | Shingrix, Arexvy |
| Pfizer INC. | $62.78 | 2024-2025 | |
| Novo Nordisk INC | $58.14 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Dexcom, INC. | $52.34 | 2025 | Dexcom G6 Transmitter |
| Sanofi-Aventis U.S. LLC | $42.94 | 2024 | |
| Sanofi Pasteur INC. | $25.00 | 2019 | |
| Inari Medical, INC. | $24.96 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Ethicon INC. | $22.58 | 2022 | |
| Edwards Lifesciences Corporation | $18.79 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Exact Sciences Corporation | $17.90 | 2023 | Cologuard Collection Kit |
| Gilead Sciences, INC. | $15.35 | 2024 | |
| Travere Therapeutics, INC. | $1.10 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tim Huston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.